Warrant
Issued 2025
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
CABA$1.430.00%
Cabaletta Bio, Inc.
Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$242.45M
Float & O/S:
Inst Own:
DilutionScan read 41 of Cabaletta Bio, Inc.'s SEC filings and found 2 warrant series, 2 ATM programs, 3 shelf registrations and 3 completed offerings on file for CABA. The latest dilution event on file is ATM sales on Aug 13, 2026. Analysis updated Oct 31, 2026.
Signal8 Summary
CABA
Going-concern warning, pre-revenue biotech
Snapshot
Cabaletta is a pre-revenue, clinical-stage biotech with no products on the market and a FY 2025 net loss of $167.9M. It holds $225.1M in cash but burns cash quickly, and Signal8 models roughly 14.1 months of runway.
What's Happening Right Now
- : Cabaletta disclosed on Sept 14, 2026 that warrants from its June 2025 offering expired, with about 51.3 million exercised for roughly $128.2M in proceeds, adding about 51 million new shares.
- : Cabaletta's 10-Q (filed Sept 9, 2026) states substantial doubt about its ability to continue as a going concern, with cash funding operations only into mid-2027 and a Q2 2026 net loss of $51.0M.
- : On Aug 13, 2026, Cabaletta reported a $51.0M Q2 2026 net loss and said its $225.1M cash position, boosted by a May 2026 offering, is expected to fund operations into mid-2027, while reaffirming mid-2027 myositis data and a planned second-half-2027 BLA filing.
Raise routes on file: active ATM + effective shelf · latest dilution event 82 days ago
Overall Risk
Offering Ability
Overhead Supply
Historical
Cash Need
AI dilution summary
The dominant contractual driver and its mechanism, then each further driver ranked.
Latest dilution event
Aug 13, 2026 · ATM Sale
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Share count and cash history
Shares outstanding, potential dilution and cash over time
Expired
June 2025 Pre-Funded Warrants
Issued 2025
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
ATM program
Issued 2024
Total capacity
Sold to date
Remaining capacity
- Sales agent
- Agreement date
- Commission
ATM program
Issued 2025
Total capacity
Sold to date
Remaining capacity
- Sales agent
- Agreement date
- Commission
S-3ASR (converted to S-3 by post-effective amendments) shelf registration
Issued 2024
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
S-3 shelf registration
Issued 2025
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
S-3 shelf registration
Issued 2023
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
Registered direct offering
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Offering
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Offering
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Know who's about to sell into your CABA trade
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
